1. Competition, value-based prices and incentives to research personalised drugs. (2024). LEVAGGI, ROSELLA.
   In: Socio-Economic Planning Sciences.
   RePEc:eee:soceps:v:93:y:2024:i:c:s0038012124000697.

   Full description at Econpapers || Download paper

2. The Relevance of Including Future Healthcare Costs in Cost-Effectiveness Threshold Calculations for the UK NHS. (2022). Asaria, Miqdad ; Baal, Pieter ; Perry-Duxbury, Megan ; Lomas, James.
   In: PharmacoEconomics.
   RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-021-01090-x.

   Full description at Econpapers || Download paper

3. Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy. (2022). Towse, Adrian ; Sampson, Christopher ; Devlin, Nancy ; Garcia-Lorenzo, Borja ; Zamora, Bernarda ; Leech, Ashley A ; Watson, Sam ; Cubi-Molla, Patricia ; Chalkidou, Kalipso ; Cairns, John ; Hughes, Dyfrig A.
   In: Applied Health Economics and Health Policy.
   RePEc:spr:aphecp:v:20:y:2022:i:5:d:10.1007_s40258-022-00730-3.

   Full description at Econpapers || Download paper

4. Strategies for Avoiding Neglect of Opportunity Costs by Decision-Makers. (2022). Karnon, Jonathan ; Afzali, Hossein ; Partington, Andrew.
   In: Applied Health Economics and Health Policy.
   RePEc:spr:aphecp:v:20:y:2022:i:1:d:10.1007_s40258-021-00681-1.

   Full description at Econpapers || Download paper

5. Avoiding Opportunity Cost Neglect in Cost-Effectiveness Analysis for Health Technology Assessment. (2022). Faria, Rita ; Ochalek, Jessica ; Lomas, James.
   In: Applied Health Economics and Health Policy.
   RePEc:spr:aphecp:v:20:y:2022:i:1:d:10.1007_s40258-021-00679-9.

   Full description at Econpapers || Download paper

6. The relevance of including future healthcare costs in cost-effectiveness threshold calculations for the UK NHS. (2022). Asaria, Miqdad ; van Baal, Pieter ; Perry-Duxbury, Megan ; Lomas, James.
   In: LSE Research Online Documents on Economics.
   RePEc:ehl:lserod:112503.

   Full description at Econpapers || Download paper

7. The health cost of reducing hospital bed capacity. (2022). Henriksson, Martin ; Siverskog, Jonathan.
   In: Social Science & Medicine.
   RePEc:eee:socmed:v:313:y:2022:i:c:s0277953622007055.

   Full description at Econpapers || Download paper

8. NICE’s Discounting Review: Clear Thinking on Rational Revision Meets Obstacle of Industrial Interests. (2021). Paulden, Mike ; Omahony, James F ; McCabe, Chris.
   In: PharmacoEconomics.
   RePEc:spr:pharme:v:39:y:2021:i:2:d:10.1007_s40273-020-00990-8.

   Full description at Econpapers || Download paper

9. Mutually Exclusive Interventions in the Cost-Effectiveness Bookshelf. (2020). Henriksson, Martin ; Siverskog, Jonathan.
   In: Medical Decision Making.
   RePEc:sae:medema:v:40:y:2020:i:3:p:399-403.

   Full description at Econpapers || Download paper

10. Applying a Multicriteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL). (2018). Hampson, Grace ; Garau, Martina ; Devlin, Nancy ; Profico, Antonio ; Mazzanti, Nicola Amedeo.
    In: PharmacoEconomics - Open.
    RePEc:spr:pharmo:v:2:y:2018:i:2:d:10.1007_s41669-017-0048-x.

    Full description at Econpapers || Download paper

11. Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System. (2018). Cheng, Terence ; Edney, Laura Catherine ; Karnon, Jonathan ; Ali, Hossein Haji.
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:36:y:2018:i:2:d:10.1007_s40273-017-0585-2.

    Full description at Econpapers || Download paper

12. Using CART to Identify Thresholds and Hierarchies in the Determinants of Funding Decisions. (2017). Mortimer, Duncan ; Dalziel, Kim ; Schilling, Chris.
    In: Medical Decision Making.
    RePEc:sae:medema:v:37:y:2017:i:2:p:173-182.

    Full description at Econpapers || Download paper

13. Rationing in health care provision: a welfare approach. (2017). LEVAGGI, ROSELLA.
    In: International Journal of Health Economics and Management.
    RePEc:kap:ijhcfe:v:17:y:2017:i:2:d:10.1007_s10754-016-9209-1.

    Full description at Econpapers || Download paper

14. Sustainable Financing of Innovative Therapies: A Review of Approaches. (2016). Hollis, Aidan.
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:34:y:2016:i:10:d:10.1007_s40273-016-0416-x.

    Full description at Econpapers || Download paper

15. Cost-Effectiveness of Cetuximab for Advanced Esophageal Squamous Cell Carcinoma. (2016). Polinder, Suzanne ; Bruno, Marco J ; Peppelenbosch, Maikel P ; Lordick, Florian ; Janmaat, Vincent T ; Lorenzen, Sylvie.
    In: PLOS ONE.
    RePEc:plo:pone00:0153943.

    Full description at Econpapers || Download paper

16. Welfare analysis of rationing in health care provision. (2016). LEVAGGI, ROSELLA.
    In: Working papers.
    RePEc:ipu:wpaper:39.

    Full description at Econpapers || Download paper

17. Supporting the development of an essential health package: principles and initial assessment for Malawi. (2016). Sculpher, Mark ; Revill, Paul ; Claxton, Karl ; Ochalek, Jessica ; Rollinger, Alexandra.
    In: Working Papers.
    RePEc:chy:respap:136cherp.

    Full description at Econpapers || Download paper

18. The Influence of Cost‐Effectiveness and Other Factors on Nice Decisions. (2015). Rice, Nigel ; Parkin, David ; O'Neill, Phill ; Feng, Yan ; Devlin, Nancy ; Dakin, Helen.
    In: Health Economics.
    RePEc:wly:hlthec:v:24:y:2015:i:10:p:1256-1271.

    Full description at Econpapers || Download paper

19. Local health care expenditure plans and their opportunity costs. (2015). Karlsberg, Sarah ; Karlsberg Schaffer, Sarah ; Devlin, Nancy ; Sussex, Jon ; Walker, Andrew.
    In: Health Policy.
    RePEc:eee:hepoli:v:119:y:2015:i:9:p:1237-1244.

    Full description at Econpapers || Download paper

20. STAR€”People-Powered Prioritization. (2014). Airoldi, Mara ; Bevan, Gwyn ; Morton, Alec.
    In: Medical Decision Making.
    RePEc:sae:medema:v:34:y:2014:i:8:p:965-975.

    Full description at Econpapers || Download paper

21. Pricing schemes for new drugs: A welfare analysis. (2014). LEVAGGI, ROSELLA.
    In: Social Science & Medicine.
    RePEc:eee:socmed:v:102:y:2014:i:c:p:69-73.

    Full description at Econpapers || Download paper

22. Balancing equity and efficiency in the Dutch basic benefits package using the principle of proportional shortfall. (2013). van Exel, Job ; Brouwer, Werner ; Wetering, E. ; Stolk, E..
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:14:y:2013:i:1:p:107-115.

    Full description at Econpapers || Download paper

23. Critique of CHE Research Paper 81: Methods for the Estimation of the NICE Cost Effectiveness Threshold. (2013). Towse, Adrian ; Karlsberg, Sarah ; Karlsberg Schaffer, Sarah ; Barnsley, P ; Sussex, J.
    In: Occasional Paper.
    RePEc:ohe:occpap:000106.

    Full description at Econpapers || Download paper

24. The influence of cost-effectiveness and other factors on NICE decisions. (2013). Rice, Nigel ; Parkin, David ; Devlin, Nancy ; Feng, Yan ; OaNeill, Phill ; Dakin, Helen.
    In: Working Papers.
    RePEc:chy:respap:93cherp.

    Full description at Econpapers || Download paper

25. Comparing costs and outcomes across programmes of health care. (2012). Rice, Nigel ; Martin, Stephen ; Smith, Peter C..
    In: Health Economics.
    RePEc:wly:hlthec:v:21:y:2012:i:3:p:316-337.

    Full description at Econpapers || Download paper

26. The Cost Effectiveness of Newer Epilepsy Treatments. (2012). Bolin, Kristian ; Forsgren, Lars .
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:30:y:2012:i:10:p:903-923.

    Full description at Econpapers || Download paper

27. The monetary value of a life year: evidence from a qualitative study of treatment costs. (2011). Richardson, Jeff ; Hurworth, Rosalind ; McKie, John ; Shrimpton, Bradley .
    In: Health Economics.
    RePEc:wly:hlthec:v:20:y:2011:i:8:p:945-957.

    Full description at Econpapers || Download paper

28. Welfare properties of restrictions to health care based on cost effectiveness. (2011). LEVAGGI, ROSELLA.
    In: Health Economics.
    RePEc:wly:hlthec:v:20:y:2011:i:1:p:101-110.

    Full description at Econpapers || Download paper

29. Shifting the risk in pricing and reimbursement schemes? A model of risk-sharing agreements for innovative drugs. (2011). LEVAGGI, ROSELLA ; Capri, Stefano.
    In: DEP - series of economic working papers.
    RePEc:gea:wpaper:2/2011.

    Full description at Econpapers || Download paper

30. Appropriate Perspectives for Health Care Decisions. (2010). Walker, Simon ; Sculpher, Mark ; Claxton, Karl ; Palmer, Steven.
    In: Working Papers.
    RePEc:chy:respap:54cherp.

    Full description at Econpapers || Download paper

31. Why Should Economic Evaluations of Medical Innovations Have a Societal Perspective?. (2009). Johannesson, Magnus ; Zethraeus, N ; Jonsson, L ; Kobelt, G.
    In: Briefing.
    RePEc:ohe:briefg:000228.

    Full description at Econpapers || Download paper

1. Dakin, H. ; Devlin, N. ; Odeymi, I. Yes, no or ‘yes, but’: a multinomial model of NICE decisions. 2006 Health Policy. 77 352-367
   Paper not yet in RePEc: Add citation now
   
2. Derrett, S. ; Devlin, N. ; Hansen, P. ; Herbison, P. Prioritizing patients for elective surgery: a prospective study of clinical priority assessment criteria in New Zealand. 2003 International Journal of Technology Assessment in Health Care. 19 91-105
   Paper not yet in RePEc: Add citation now
   

3. Devlin, N. ; Parkin, D. Does NICE have a cost effectiveness threshold and what other factors influence its decisions? A binary choice analysis. 2004 Health Economics. 13 437-452

4. Hadorn, D.C. ; Holmes, A.C. The New Zealand priority criteria project. Part 1: Overview. 1997 BMJ. 314 131-134
   Paper not yet in RePEc: Add citation now
   

5. Martin S, Rice N, Smith PC. The link between health care spending and health outcomes for the new English primary care trusts. CHE Research Paper 42, University of York, York; 2008.

6. NICE. Appraising end of life medicines. http://www.nice.org.uk/newsevents/infocus/EndOfLifeMedicinesConsultation.jsp; November 5, 2008.
   Paper not yet in RePEc: Add citation now
   
7. NICE. Guide to the methods of technology appraisal (reference N0515). April 2004. http://www.nice.org.uk/niceMedia/pdf/TAP_Methods.pdf; 2004.
   Paper not yet in RePEc: Add citation now
   
8. NICE. Social value judgements guideline. Principles for the development of NICE guidance. London; 2005.
   Paper not yet in RePEc: Add citation now
   
9. Rawlins M. Fifteen minutes with Professor Sir Michael Rawlins. BMJ Career Focus. http://careers.bmj.com/careers/advice/view-article.html?id=1419; 2006.
   Paper not yet in RePEc: Add citation now
   
10. Rawlins, M. ; Culyer, A. National Institute for Clinical Excellence and its value judgments. 2004 BMJ. 329 224-227
    Paper not yet in RePEc: Add citation now
    
11. Richards M. Improving access to medicines for NHS patients: a report for the Secretary of State for Health by Professor Mike Richards. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_089927; November 4, 2008.
    Paper not yet in RePEc: Add citation now
    

12. Williams, A. What could be nicer than NICE?. 2004 Office for Health Economics: London

1. Cost-effectiveness thresholds in health care: a bookshelf guide to their meaning and use. (2015). Culyer, Anthony.
   In: Working Papers.
   RePEc:chy:respap:121cherp.

   Full description at Econpapers || Download paper

2. A Comparative Analysis of Models Used to Evaluate the Cost-Effectiveness of Dabigatran Versus Warfarin for the Prevention of Stroke in Atrial Fibrillation. (2013). Sorensen, Sonja ; Peng, Siyang ; Bradley-Kennedy, Carole ; Monz, Brigitta ; Kansal, Anuraag .
   In: PharmacoEconomics.
   RePEc:spr:pharme:v:31:y:2013:i:7:p:589-604.

   Full description at Econpapers || Download paper

3. Decision-Makers’ Preferences for Approving New Medicines in Wales: A Discrete-Choice Experiment with Assessment of External Validity. (2013). Linley, Warren ; Hughes, Dyfrig.
   In: PharmacoEconomics.
   RePEc:spr:pharme:v:31:y:2013:i:4:p:345-355.

   Full description at Econpapers || Download paper

4. A Person Trade-Off Study to Estimate Age-Related Weights for Health Gains in Economic Evaluation. (2013). Petrou, Stavros ; Baker, Rachel ; Kandala, Ngianga-Bakwin ; Robinson, Angela.
   In: PharmacoEconomics.
   RePEc:spr:pharme:v:31:y:2013:i:10:p:893-907.

   Full description at Econpapers || Download paper

5. Balancing equity and efficiency in the Dutch basic benefits package using the principle of proportional shortfall. (2013). van Exel, Job ; Brouwer, Werner ; Wetering, E. ; Stolk, E..
   In: The European Journal of Health Economics.
   RePEc:spr:eujhec:v:14:y:2013:i:1:p:107-115.

   Full description at Econpapers || Download paper

6. Transparency vs. closed-door policy: Do process characteristics have an impact on the outcomes of coverage decisions? A statistical analysis. (2013). Leidl, Reiner ; Blankart, Katharina ; Rogowski, Wolf H. ; Fischer, Katharina E. ; Stollenwerk, Bjorn.
   In: Health Policy.
   RePEc:eee:hepoli:v:112:y:2013:i:3:p:187-196.

   Full description at Econpapers || Download paper

7. Drug reimbursement recommendations by the National Institute for Health and Clinical Excellence: Have they impacted the National Health Service budget?. (2013). Bowman, Lee ; Boye, Kristina S. ; Birt, Julie ; Mauskopf, Josephine ; Chirila, Costel .
   In: Health Policy.
   RePEc:eee:hepoli:v:110:y:2013:i:1:p:49-59.

   Full description at Econpapers || Download paper

8. The influence of cost-effectiveness and other factors on NICE decisions. (2013). Rice, Nigel ; Parkin, David ; Devlin, Nancy ; Feng, Yan ; OaNeill, Phill ; Dakin, Helen.
   In: Working Papers.
   RePEc:chy:respap:93cherp.

   Full description at Econpapers || Download paper

9. Reimbursement Decisions of the All Wales Medicines Strategy Group. (2012). Linley, Warren ; Hughes, Dyfrig.
   In: PharmacoEconomics.
   RePEc:spr:pharme:v:30:y:2012:i:9:p:779-794.

   Full description at Econpapers || Download paper

10. Clopidogrel versus Aspirin in Patients with Atherothrombosis. (2012). Fragoulakis, Vassilis ; Maniadakis, Nikos ; Kourlaba, Georgia.
    In: Applied Health Economics and Health Policy.
    RePEc:spr:aphecp:v:10:y:2012:i:5:p:331-342.

    Full description at Econpapers || Download paper

11. Economic Evaluation of Clopidogrel in Acute Coronary Syndrome Patients without ST-Segment Elevation in Greece. (2012). Fragoulakis, Vassilis ; Maniadakis, Nikos ; Kourlaba, Georgia.
    In: Applied Health Economics and Health Policy.
    RePEc:spr:aphecp:v:10:y:2012:i:4:p:261-271.

    Full description at Econpapers || Download paper

12. The Willingness to Pay for a QALY - Results based on value of statistical life estimates in Sweden. (2012). Svensson, Mikael ; Hultkrantz, Lars.
    In: Karlstad University Working Papers in Economics.
    RePEc:hhs:kaunek:0002.

    Full description at Econpapers || Download paper

13. What counts and how to count it: Physicians’ constructions of evidence in a disinvestment context. (2012). Hodgetts, Katherine ; Hiller, Janet E. ; Elshaug, Adam G..
    In: Social Science & Medicine.
    RePEc:eee:socmed:v:75:y:2012:i:12:p:2191-2199.

    Full description at Econpapers || Download paper

14. A systematic review of coverage decision-making on health technologies—Evidence from the real world. (2012). Blankart, Katharina ; Fischer, Katharina Elisabeth .
    In: Health Policy.
    RePEc:eee:hepoli:v:107:y:2012:i:2:p:218-230.

    Full description at Econpapers || Download paper

15. Twenty Years of Using Economic Evaluations for Reimbursement Decisions. What Have We Achieved?. (2012). Drummond, Michael.
    In: Working Papers.
    RePEc:chy:respap:75cherp.

    Full description at Econpapers || Download paper

16. Sample Size and Power for Cost-Effectiveness Analysis (Part 2). (2011). Glick, Henry .
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:29:y:2011:i:4:p:287-296.

    Full description at Econpapers || Download paper

17. Sample Size and Power for Cost-Effectiveness Analysis (Part 1). (2011). Glick, Henry .
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:29:y:2011:i:3:p:189-198.

    Full description at Econpapers || Download paper

18. Deliberating Tarceva: A case study of how British NHS managers decide whether to purchase a high-cost drug in the shadow of NICE guidance. (2011). Doheny, Shane ; Hughes, David.
    In: Social Science & Medicine.
    RePEc:eee:socmed:v:73:y:2011:i:10:p:1460-1468.

    Full description at Econpapers || Download paper

19. A structured tool to analyse coverage decisions: Development and feasibility test in the field of cancer screening and prevention. (2011). Leidl, Reiner ; Blankart, Katharina ; Rogowski, Wolf H. ; Fischer, Katharina E..
    In: Health Policy.
    RePEc:eee:hepoli:v:101:y:2011:i:3:p:290-299.

    Full description at Econpapers || Download paper

20. Fixing the game: are between‐silo differences in funding arrangements handicapping some interventions and giving others a head‐start?. (2010). Mortimer, Duncan ; Segal, Leonie ; Dalziel, Kim.
    In: Health Economics.
    RePEc:wly:hlthec:v:19:y:2010:i:4:p:449-465.

    Full description at Econpapers || Download paper

21. International survey on willingness‐to‐pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?. (2010). Shiroiwa, Takeru ; Fukuda, Takashi ; Bae, Sang-Cheol ; Tsutani, Kiichiro ; Lang, Hui-Chu ; Sung, Yoon-Kyoung.
    In: Health Economics.
    RePEc:wly:hlthec:v:19:y:2010:i:4:p:422-437.

    Full description at Econpapers || Download paper

22. Valuing health technologies at nice: recommendations for improved incorporation of treatment value in HTA. (2010). Yin, Wesley ; Philipson, Tomas ; Lakdawalla, Darius ; Goldman, Dana.
    In: Health Economics.
    RePEc:wly:hlthec:v:19:y:2010:i:10:p:1109-1116.

    Full description at Econpapers || Download paper

23. An economic evaluation of the war on cancer. (2010). Sun, Eric ; Philipson, Tomas ; Lakdawalla, Darius ; Jena, Anupam ; Goldman, Dana ; Reyes, Carolina M..
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:29:y:2010:i:3:p:333-346.

    Full description at Econpapers || Download paper

24. Do current levels of air pollution kill? The impact of air pollution on population mortality in England. (2009). Propper, Carol ; Janke, Katharina ; Henderson, John.
    In: Health Economics.
    RePEc:wly:hlthec:v:18:y:2009:i:9:p:1031-1055.

    Full description at Econpapers || Download paper

25. Exploring the social value of health‐care interventions: a stated preference discrete choice experiment. (2009). Gerard, Karen ; Green, Colin.
    In: Health Economics.
    RePEc:wly:hlthec:v:18:y:2009:i:8:p:951-976.

    Full description at Econpapers || Download paper

26. Long‐term care and hospital utilisation by older people: an analysis of substitution rates. (2009). Forder, Julien.
    In: Health Economics.
    RePEc:wly:hlthec:v:18:y:2009:i:11:p:1322-1338.

    Full description at Econpapers || Download paper

27. Cost Effectiveness in Low- and Middle-Income Countries. (2009). Shillcutt, Samuel ; Walker, Damian ; Goodman, Catherine ; Mills, Anne.
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:27:y:2009:i:11:p:903-917.

    Full description at Econpapers || Download paper

28. Economic Evaluation and Cost-Effectiveness Thresholds. (2009). Goldberg, Robert ; Golec, Joseph ; Vernon, John .
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:27:y:2009:i:10:p:797-806.

    Full description at Econpapers || Download paper

29. An Economic Evaluation of the War on Cancer. (2009). Sun, Eric ; Philipson, Tomas ; Lakdawalla, Darius ; Jena, Anupam ; Goldman, Dana ; Reyes, Carolina M..
    In: NBER Working Papers.
    RePEc:nbr:nberwo:15574.

    Full description at Econpapers || Download paper

30. Axiomatic Foundations of Cost Effectiveness Analysis. (2009). canning, david.
    In: PGDA Working Papers.
    RePEc:gdm:wpaper:5109.

    Full description at Econpapers || Download paper

31. Partially wrong? Partial equilibrium and the economic analysis of public health emergencies of international concern. (2008). Edmunds, W. J. ; Smith, R. D. ; Beutels, P..
    In: Health Economics.
    RePEc:wly:hlthec:v:17:y:2008:i:11:p:1317-1322.

    Full description at Econpapers || Download paper

32. Optimal drug pricing, limited use conditions and stratified net benefits for Markov models of disease progression. (2008). Zaric, Gregory S..
    In: Health Economics.
    RePEc:wly:hlthec:v:17:y:2008:i:11:p:1277-1294.

    Full description at Econpapers || Download paper

33. Bridging the gap between health and non-health investments: moving from cost-effectiveness analysis to a return on investment approach across sectors of economy. (2008). Sendi, Pedram.
    In: International Journal of Health Economics and Management.
    RePEc:kap:ijhcfe:v:8:y:2008:i:2:p:113-121.

    Full description at Econpapers || Download paper

34. Equity weights for economic evaluation: An Australian Discrete Choice Experiment, CHERE Working Paper 2008/5. (2008). Norman, Richard ; Gallego, Gisselle.
    In: Working Papers.
    RePEc:her:chewps:2008/5.

    Full description at Econpapers || Download paper

35. Measuring Preferences for Cost-Utility Analysis. (2007). McDonough, Christine ; Tosteson, Anna .
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:25:y:2007:i:2:p:93-106.

    Full description at Econpapers || Download paper

36. Cost Effectiveness of Palivizumab for Respiratory Syncytial Virus Prophylaxis in High-Risk Children. (2007). Wittenberg, Wolfgang ; Lebmeier, Maximilian ; Nuijten, Mark.
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:25:y:2007:i:1:p:55-71.

    Full description at Econpapers || Download paper

37. Understanding the limited impact of economic evaluation in health care resource allocation: A conceptual framework. (2007). Bryan, Stirling ; Williams, Iestyn.
    In: Health Policy.
    RePEc:eee:hepoli:v:80:y:2007:i:1:p:135-143.

    Full description at Econpapers || Download paper

38. Are current levels of air pollution in England too high? The impact of pollution on population mortality. (2007). Janke, Katharina ; Henderson, John ; Propper, Carol.
    In: CASE Papers.
    RePEc:cep:sticas:/128.

    Full description at Econpapers || Download paper

39. Non‐linearity in the cost‐effectiveness frontier. (2006). Lord, Joanne ; Laking, George ; Fischer, Alastair .
    In: Health Economics.
    RePEc:wly:hlthec:v:15:y:2006:i:6:p:565-577.

    Full description at Econpapers || Download paper

40. Does the National Institute for Health and Clinical Excellence take account of factors such as uncertainty and equity as well as incremental cost-effectiveness in commissioning health care services? A binary choice experiment. (2006). Brazier, John ; Tappenden, P ; Ratcliffe, J.
    In: MPRA Paper.
    RePEc:pra:mprapa:29772.

    Full description at Econpapers || Download paper

41. An Internet “Value of Health” panel: recruitment, participation and compliance. (2006). Brazier, John ; Dyer, M ; Stein, K ; Ratcliffe, J ; Round, A ; Crabb, T ; Milne, R.
    In: MPRA Paper.
    RePEc:pra:mprapa:29770.

    Full description at Econpapers || Download paper

42. Providing guidance to the NHS: The Scottish Medicines Consortium and the National Institute for Clinical Excellence compared. (2006). Cairns, John.
    In: Health Policy.
    RePEc:eee:hepoli:v:76:y:2006:i:2:p:134-143.

    Full description at Econpapers || Download paper

43. Are General Practitioners Good for Endogenous Supply and Health. (2006). Morris, Stephen ; Gravelle, Hugh ; Sutton, Matt.
    In: Working Papers.
    RePEc:chy:respap:20cherp.

    Full description at Econpapers || Download paper

44. Pricing and Reimbursement of Prescription Drugs in German Social Health Insurance. (2006). Gre, Stefan ; Wasem, Jurgen.
    In: ifo DICE Report.
    RePEc:ces:ifodic:v:4:y:2006:i:2:p:39-47.

    Full description at Econpapers || Download paper

45. Trial-based cost-utility comparison of percutaneous myocardial laser revascularisation and continued medical therapy for treatment of refractory angina pectoris. (2005). Schofield, Peter ; Caine, Noreen ; Buxton, Martin ; Sharples, Linda ; Campbell, Helen ; Gray, Timothy ; Tait, Sue .
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:6:y:2005:i:4:p:288-297.

    Full description at Econpapers || Download paper

46. How much are health-care systems prepared to pay to produce a QALY?. (2005). Buxton, Martin.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:6:y:2005:i:4:p:285-287.

    Full description at Econpapers || Download paper

47. Practice guidelines based on clinical and economic evidence. (2005). Niessen, Louis ; Brouwer, Werner.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:6:y:2005:i:2:p:91-93.

    Full description at Econpapers || Download paper

48. Criteria for determining a basic health services package. (2005). Poley, M. ; Stolk, E..
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:6:y:2005:i:1:p:2-7.

    Full description at Econpapers || Download paper

49. The cost of epidemiological transition: A study of a decrease in pertussis vaccination coverage. (2005). Girard, Dorota Zdanowska.
    In: Health Policy.
    RePEc:eee:hepoli:v:74:y:2005:i:3:p:287-303.

    Full description at Econpapers || Download paper

50. Developing new approaches to measuring NHS outputs and productivity. (2005). Weale, Martin ; Stokes, Lucy ; Street, Andrew ; Stevens, Philip ; O'MAHONY, Mary ; Gravelle, Hugh ; Castelli, Adriana ; Kind, Paul ; Dawson, Diane ; Martin, Stephen ; Jacobs, Rowena ; Loveridge, Pete.
    In: Working Papers.
    RePEc:chy:respap:6cherp.

    Full description at Econpapers || Download paper

Report date: 2025-10-05 02:42:31 || Missing content? Let us know